{"gene":"APIP","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2004,"finding":"APIP binds to the CARD domain of Apaf-1 in competition with caspase-9, thereby inhibiting cytochrome c-induced activation of caspase-3 and caspase-9 and suppressing mitochondrial apoptosis.","method":"Co-immunoprecipitation (binding to Apaf-1 CARD), in vitro caspase activation assay, overexpression/knockdown with apoptosis readouts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assay plus functional caspase assays plus loss-of-function, replicated across multiple contexts","pmids":["15262985"],"is_preprint":false},{"year":2006,"finding":"APIP promotes survival during hypoxia through an Apaf-1-independent mechanism: it induces sustained activation of AKT and ERK1/2, leading to phosphorylation of caspase-9 (at T125 and S196), which suppresses hypoxia-induced cell death.","method":"Stable overexpression in C2C12 cells, PI3K/MEK inhibitor treatment, phospho-mimic and phospho-defective caspase-9 mutants, cell death assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including pharmacological inhibitors and structure-function mutagenesis in a single study","pmids":["17086211"],"is_preprint":false},{"year":2013,"finding":"APIP functions as a 5-methylthioribulose-1-phosphate dehydratase (MtnB) in the methionine salvage pathway, with Km = 9.32 µM and Vmax = 1.39 µmol/min/mg; its crystal structure at 2.0-Å resolution reveals a zinc-dependent class II aldolase fold, a tetrameric assembly with C4 symmetry, and Glu139* as the catalytic acid/base. MtnB enzymatic activity is required for inhibition of caspase-1-induced pyroptosis but not for inhibition of apoptosis induced by hypoxia or etoposide.","method":"Crystal structure determination (2.0-Å resolution), enzymatic kinetics assay, active-site mutagenesis (E139 mutant), substrate-docking, sequence conservation analysis, cell death assays with enzymatic mutants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus enzymatic reconstitution plus active-site mutagenesis in a single rigorous study","pmids":["24367089"],"is_preprint":false},{"year":2012,"finding":"APIP is the human MtnB enzyme (5-methylthioribulose-1-phosphate dehydratase) of the methionine salvage pathway; its zinc-binding site is essential for activity, the N-terminal region (absent in the short isoform) is required for activity, and mutation of potential phosphorylation sites does not affect activity.","method":"shRNA knockdown in HeLa cells with MTA-based growth rescue assay, Shigella methionine-auxotroph complementation, site-directed mutagenesis of zinc-binding and phosphorylation sites","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — functional complementation plus mutagenesis in two orthogonal cell-based systems","pmids":["23285211"],"is_preprint":false},{"year":2016,"finding":"APIP binds to ERBB3 in response to heregulin-β1 stimulation, enhances ERBB3-ERBB2 heterodimer formation, and promotes sustained ERK1/2 and AKT activation, thereby driving cell proliferation and tumorigenesis independently of its methionine salvage pathway function.","method":"Co-immunoprecipitation (APIP-ERBB3 and ERBB3-ERBB2 binding), APIP knockdown/overexpression with proliferation and tumor formation assays, APIP transgenic and knockout MEFs","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus genetic gain/loss-of-function with multiple functional readouts","pmids":["26942872"],"is_preprint":false},{"year":2019,"finding":"APIP physically interacts with the adenosine receptor ADORA2B, stabilizing both proteins by interfering with lysosomal degradation, and activates downstream PKA-CREB signaling and the AKT-HIF1α pathway to protect cardiomyocytes against hypoxic/ischemic injury. The ADORA2B D296G variant (rs200741295 polymorphism) fails to bind APIP and loses cardioprotective activity.","method":"Co-immunoprecipitation, proximity ligation assay, APIP transgenic and heterozygous knockout mice (infarct size after LAD ligation), ADORA2B D296G knock-in mice, APIP knockdown in neonatal cardiomyocytes","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus proximity ligation assay plus multiple in vivo genetic models with defined phenotypic readout","pmids":["31263105"],"is_preprint":false},{"year":2024,"finding":"YAP transcriptionally activates APIP expression; elevated APIP promotes methionine cycle activity, leading to phosphorylation and inactivation of GSK3β and subsequent induction of epithelial-mesenchymal transition, thereby driving HNSCC cell migration, invasion, and lymph node/distant metastasis.","method":"RNA sequencing, metabolomics (UHPLC-MS/MS), APIP knockdown with migration/invasion assays, in vivo metastasis model, methionine rescue experiment, YAP-APIP transcriptional activation assay","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (transcriptomics, metabolomics, genetic KD, rescue) in a single lab study","pmids":["38423248"],"is_preprint":false},{"year":2025,"finding":"APIP binds to TRAF6, activating downstream NF-κB and JNK signaling to facilitate priming of both canonical NLRP3 and non-canonical caspase-11/caspase-4 inflammasomes; myeloid-specific APIP knockout reduces pyroptosis and systemic inflammation, while APIP overexpression exacerbates it.","method":"Co-immunoprecipitation (APIP-TRAF6), myeloid-specific conditional knockout mice (Apip cKO), APIP transgenic mice, APIP knockdown in human macrophages, LPS/bacterial infection models, NF-κB/JNK activity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus multiple genetic models (cKO, transgenic, KD) with defined mechanistic pathway and in vivo phenotype","pmids":["41339302"],"is_preprint":false}],"current_model":"APIP is a multifunctional protein that (1) inhibits apoptosis by binding the Apaf-1 CARD to block apoptosome assembly and by activating AKT/ERK1/2-mediated caspase-9 phosphorylation during hypoxia; (2) acts as the MtnB dehydratase enzyme (zinc-dependent, Glu139* catalytic base, tetrameric) in the methionine salvage pathway, with this enzymatic activity required for suppression of pyroptosis but not apoptosis; (3) binds ERBB3 to stabilize ERBB2-ERBB3 heterodimers and sustain pro-survival signaling; (4) interacts with ADORA2B to prevent lysosomal degradation and activate PKA-CREB/AKT-HIF1α cardioprotective signaling; and (5) binds TRAF6 to prime canonical NLRP3 and non-canonical caspase-11/4 inflammasomes via NF-κB and JNK activation."},"narrative":{"teleology":[{"year":2004,"claim":"Establishing the anti-apoptotic identity of APIP: it was unknown how APIP influenced cell death, and binding to the Apaf-1 CARD in competition with caspase-9 revealed a direct mechanism for blocking apoptosome assembly and downstream caspase activation.","evidence":"Co-immunoprecipitation mapping to Apaf-1 CARD, in vitro caspase activation assays, overexpression/knockdown with apoptosis readouts in mammalian cells","pmids":["15262985"],"confidence":"High","gaps":["Whether endogenous APIP levels are sufficient to compete with caspase-9 under physiological conditions","Structural basis of the APIP–Apaf-1 CARD interaction not resolved"]},{"year":2006,"claim":"Resolving a second, Apaf-1-independent anti-apoptotic mechanism: APIP sustains AKT and ERK1/2 activation during hypoxia, leading to inhibitory phosphorylation of caspase-9 at T125 and S196, demonstrating a kinase-mediated survival circuit distinct from apoptosome blockade.","evidence":"Stable overexpression in C2C12 cells, PI3K/MEK inhibitor treatment, phospho-mimic/phospho-defective caspase-9 mutants","pmids":["17086211"],"confidence":"High","gaps":["How APIP activates AKT/ERK1/2 upstream — direct binding partner or indirect effect unknown","Relative contribution of Apaf-1-dependent vs. kinase-dependent mechanisms in vivo"]},{"year":2012,"claim":"Identifying APIP as the human MtnB enzyme in the methionine salvage pathway established a metabolic function orthogonal to its anti-apoptotic role, with zinc coordination and the N-terminal region both required for catalysis.","evidence":"shRNA knockdown in HeLa with MTA-based growth rescue, Shigella methionine-auxotroph complementation, zinc-binding and phosphorylation-site mutagenesis","pmids":["23285211"],"confidence":"High","gaps":["Whether enzymatic and anti-apoptotic functions are regulated independently in cells"]},{"year":2013,"claim":"Crystal structure and separation-of-function analysis showed that the MtnB dehydratase activity (Glu139 catalytic base, tetrameric zinc-dependent class II aldolase fold) is specifically required for suppressing caspase-1-mediated pyroptosis but not for suppressing apoptosis, decoupling the metabolic and anti-apoptotic functions mechanistically.","evidence":"2.0-Å crystal structure, enzymatic kinetics, E139 active-site mutant tested in pyroptosis and apoptosis assays","pmids":["24367089"],"confidence":"High","gaps":["Metabolite(s) linking MtnB activity to caspase-1 suppression not identified","Whether polyamine or other methionine salvage intermediates are the effector species"]},{"year":2016,"claim":"Binding of APIP to ERBB3 upon heregulin-β1 stimulation stabilizes ERBB2–ERBB3 heterodimers and prolongs ERK/AKT signaling, providing a receptor-level mechanism for APIP-driven proliferation and tumorigenesis independent of methionine salvage.","evidence":"Reciprocal Co-IP of APIP–ERBB3 and ERBB3–ERBB2, APIP knockout/transgenic MEFs, tumor formation assays","pmids":["26942872"],"confidence":"High","gaps":["Binding interface between APIP and ERBB3 not mapped","Whether APIP affects other ERBB-family heterodimers"]},{"year":2019,"claim":"APIP interaction with ADORA2B prevents lysosomal degradation of both proteins and activates PKA-CREB and AKT-HIF1α signaling, establishing a cardioprotective axis; the ADORA2B D296G variant abolishes binding and protection, linking a human polymorphism to loss of this function.","evidence":"Co-IP and proximity ligation assay, APIP transgenic and heterozygous KO mice with myocardial infarction model, ADORA2B D296G knock-in mice","pmids":["31263105"],"confidence":"High","gaps":["Whether APIP stabilization of ADORA2B occurs at the plasma membrane or during trafficking","No clinical cohort data linking the D296G variant to cardiac outcomes"]},{"year":2024,"claim":"YAP-driven transcriptional activation of APIP feeds methionine cycle activity, leading to GSK3β phosphorylation/inactivation and epithelial–mesenchymal transition, connecting APIP's metabolic function to metastatic behavior in HNSCC.","evidence":"RNA-seq, UHPLC-MS/MS metabolomics, APIP knockdown with invasion assays, in vivo metastasis model, methionine rescue","pmids":["38423248"],"confidence":"Medium","gaps":["Specific methionine cycle metabolite responsible for GSK3β inactivation not identified","Generalizability beyond HNSCC not tested","Single-lab study awaiting independent replication"]},{"year":2025,"claim":"APIP binds TRAF6 to activate NF-κB and JNK, thereby priming canonical NLRP3 and non-canonical caspase-11/4 inflammasomes — revealing a pro-inflammatory role that contrasts with its previously known anti-pyroptotic function.","evidence":"Reciprocal Co-IP of APIP–TRAF6, myeloid-specific conditional KO and transgenic mice, LPS/bacterial infection models, human macrophage knockdown","pmids":["41339302"],"confidence":"High","gaps":["Whether the TRAF6-mediated priming role depends on MtnB enzymatic activity","How the pro-inflammasome priming function is reconciled with earlier caspase-1 pyroptosis suppression attributed to MtnB activity","Binding interface and stoichiometry of APIP–TRAF6 complex unknown"]},{"year":null,"claim":"A unified model reconciling APIP's apparently opposing roles in promoting inflammasome priming (via TRAF6/NF-κB) yet suppressing pyroptosis (via MtnB activity) is not established; the metabolite intermediates connecting MtnB catalysis to caspase-1 inhibition remain unidentified, and the structural basis of APIP interactions with Apaf-1, ERBB3, ADORA2B, and TRAF6 has not been resolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal structure of APIP with any of its protein partners","Metabolite effector(s) linking methionine salvage to pyroptosis suppression unidentified","Context-dependent regulation that switches APIP between pro- and anti-inflammatory modes unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4,7]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3,6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,5]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7]}],"complexes":[],"partners":["APAF1","ERBB3","ERBB2","ADORA2B","TRAF6"],"other_free_text":[]},"mechanistic_narrative":"APIP is a multifunctional protein that couples metabolic enzyme activity in the methionine salvage pathway with regulation of apoptosis, pyroptosis, and pro-survival signaling. It functions as a zinc-dependent 5-methylthioribulose-1-phosphate dehydratase (MtnB) organized as a tetramer with C4 symmetry, using Glu139 as the catalytic acid/base; this enzymatic activity is required for suppression of caspase-1-mediated pyroptosis but dispensable for its anti-apoptotic functions [PMID:24367089, PMID:23285211]. APIP inhibits mitochondrial apoptosis by binding the Apaf-1 CARD domain in competition with caspase-9 and, independently, by activating AKT and ERK1/2 to phosphorylate caspase-9 during hypoxia; it also binds ERBB3 to stabilize ERBB2–ERBB3 heterodimers sustaining proliferative signaling, and interacts with ADORA2B to prevent its lysosomal degradation and activate PKA-CREB/AKT-HIF1α cardioprotective pathways [PMID:15262985, PMID:17086211, PMID:26942872, PMID:31263105]. APIP additionally binds TRAF6 to activate NF-κB and JNK, thereby priming both canonical NLRP3 and non-canonical caspase-11/4 inflammasomes, with myeloid-specific knockout reducing pyroptosis and systemic inflammation in vivo [PMID:41339302]."},"prefetch_data":{"uniprot":{"accession":"Q96GX9","full_name":"Methylthioribulose-1-phosphate dehydratase","aliases":["APAF1-interacting protein","hAPIP"],"length_aa":242,"mass_kda":27.1,"function":"Catalyzes the dehydration of methylthioribulose-1-phosphate (MTRu-1-P) into 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P). Functions in the methionine salvage pathway, which plays a key role in cancer, apoptosis, microbial proliferation and inflammation. May inhibit the CASP1-related inflammatory response (pyroptosis), the CASP9-dependent apoptotic pathway and the cytochrome c-dependent and APAF1-mediated cell death","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q96GX9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/APIP","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/APIP","total_profiled":1310},"omim":[{"mim_id":"612491","title":"APAF1-INTERACTING PROTEIN; APIP","url":"https://www.omim.org/entry/612491"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/APIP"},"hgnc":{"alias_symbol":["CGI-29","Mmrp19","APIP2"],"prev_symbol":[]},"alphafold":{"accession":"Q96GX9","domains":[{"cath_id":"3.40.225.10","chopping":"23-226","consensus_level":"medium","plddt":97.337,"start":23,"end":226}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96GX9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96GX9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96GX9-F1-predicted_aligned_error_v6.png","plddt_mean":92.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=APIP","jax_strain_url":"https://www.jax.org/strain/search?query=APIP"},"sequence":{"accession":"Q96GX9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96GX9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96GX9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96GX9"}},"corpus_meta":[{"pmid":"15262985","id":"PMC_15262985","title":"Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-interacting protein.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15262985","citation_count":59,"is_preprint":false},{"pmid":"17086211","id":"PMC_17086211","title":"Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17086211","citation_count":34,"is_preprint":false},{"pmid":"24367089","id":"PMC_24367089","title":"Structural and biochemical basis for the inhibition of cell death by APIP, a methionine salvage enzyme.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24367089","citation_count":28,"is_preprint":false},{"pmid":"22407486","id":"PMC_22407486","title":"Down-regulated expression of apoptosis-associated genes APIP and UACA in non-small cell lung carcinoma.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22407486","citation_count":24,"is_preprint":false},{"pmid":"23285211","id":"PMC_23285211","title":"Functional identification of APIP as human mtnB, a key enzyme in the methionine salvage pathway.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23285211","citation_count":22,"is_preprint":false},{"pmid":"31263105","id":"PMC_31263105","title":"Cardioprotective role of APIP in myocardial infarction through ADORA2B.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31263105","citation_count":14,"is_preprint":false},{"pmid":"26942872","id":"PMC_26942872","title":"APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26942872","citation_count":12,"is_preprint":false},{"pmid":"28123544","id":"PMC_28123544","title":"Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26.","date":"2016","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28123544","citation_count":8,"is_preprint":false},{"pmid":"38423248","id":"PMC_38423248","title":"APIP regulated by YAP propels methionine cycle and metastasis in head and neck squamous cell carcinoma.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38423248","citation_count":4,"is_preprint":false},{"pmid":"41339302","id":"PMC_41339302","title":"APIP regulates the priming of canonical NLRP3 and non-canonical Caspase-11/4 inflammasomes by binding to TRAF6.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41339302","citation_count":1,"is_preprint":false},{"pmid":"41126213","id":"PMC_41126213","title":"Clinical pathological significance and biological functions of APIP in hepatocellular carcinoma.","date":"2025","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/41126213","citation_count":0,"is_preprint":false},{"pmid":"39559319","id":"PMC_39559319","title":"NMI, POLR3G and APIP are the key molecules connecting glaucoma with high intraocular pressure: a clue for early diagnostic biomarker candidates.","date":"2024","source":"International journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/39559319","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7627,"output_tokens":2299,"usd":0.028683},"stage2":{"model":"claude-opus-4-6","input_tokens":5611,"output_tokens":2712,"usd":0.143783},"total_usd":0.172466,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"APIP binds to the CARD domain of Apaf-1 in competition with caspase-9, thereby inhibiting cytochrome c-induced activation of caspase-3 and caspase-9 and suppressing mitochondrial apoptosis.\",\n      \"method\": \"Co-immunoprecipitation (binding to Apaf-1 CARD), in vitro caspase activation assay, overexpression/knockdown with apoptosis readouts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assay plus functional caspase assays plus loss-of-function, replicated across multiple contexts\",\n      \"pmids\": [\"15262985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"APIP promotes survival during hypoxia through an Apaf-1-independent mechanism: it induces sustained activation of AKT and ERK1/2, leading to phosphorylation of caspase-9 (at T125 and S196), which suppresses hypoxia-induced cell death.\",\n      \"method\": \"Stable overexpression in C2C12 cells, PI3K/MEK inhibitor treatment, phospho-mimic and phospho-defective caspase-9 mutants, cell death assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including pharmacological inhibitors and structure-function mutagenesis in a single study\",\n      \"pmids\": [\"17086211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"APIP functions as a 5-methylthioribulose-1-phosphate dehydratase (MtnB) in the methionine salvage pathway, with Km = 9.32 µM and Vmax = 1.39 µmol/min/mg; its crystal structure at 2.0-Å resolution reveals a zinc-dependent class II aldolase fold, a tetrameric assembly with C4 symmetry, and Glu139* as the catalytic acid/base. MtnB enzymatic activity is required for inhibition of caspase-1-induced pyroptosis but not for inhibition of apoptosis induced by hypoxia or etoposide.\",\n      \"method\": \"Crystal structure determination (2.0-Å resolution), enzymatic kinetics assay, active-site mutagenesis (E139 mutant), substrate-docking, sequence conservation analysis, cell death assays with enzymatic mutants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus enzymatic reconstitution plus active-site mutagenesis in a single rigorous study\",\n      \"pmids\": [\"24367089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"APIP is the human MtnB enzyme (5-methylthioribulose-1-phosphate dehydratase) of the methionine salvage pathway; its zinc-binding site is essential for activity, the N-terminal region (absent in the short isoform) is required for activity, and mutation of potential phosphorylation sites does not affect activity.\",\n      \"method\": \"shRNA knockdown in HeLa cells with MTA-based growth rescue assay, Shigella methionine-auxotroph complementation, site-directed mutagenesis of zinc-binding and phosphorylation sites\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional complementation plus mutagenesis in two orthogonal cell-based systems\",\n      \"pmids\": [\"23285211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"APIP binds to ERBB3 in response to heregulin-β1 stimulation, enhances ERBB3-ERBB2 heterodimer formation, and promotes sustained ERK1/2 and AKT activation, thereby driving cell proliferation and tumorigenesis independently of its methionine salvage pathway function.\",\n      \"method\": \"Co-immunoprecipitation (APIP-ERBB3 and ERBB3-ERBB2 binding), APIP knockdown/overexpression with proliferation and tumor formation assays, APIP transgenic and knockout MEFs\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus genetic gain/loss-of-function with multiple functional readouts\",\n      \"pmids\": [\"26942872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"APIP physically interacts with the adenosine receptor ADORA2B, stabilizing both proteins by interfering with lysosomal degradation, and activates downstream PKA-CREB signaling and the AKT-HIF1α pathway to protect cardiomyocytes against hypoxic/ischemic injury. The ADORA2B D296G variant (rs200741295 polymorphism) fails to bind APIP and loses cardioprotective activity.\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation assay, APIP transgenic and heterozygous knockout mice (infarct size after LAD ligation), ADORA2B D296G knock-in mice, APIP knockdown in neonatal cardiomyocytes\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus proximity ligation assay plus multiple in vivo genetic models with defined phenotypic readout\",\n      \"pmids\": [\"31263105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"YAP transcriptionally activates APIP expression; elevated APIP promotes methionine cycle activity, leading to phosphorylation and inactivation of GSK3β and subsequent induction of epithelial-mesenchymal transition, thereby driving HNSCC cell migration, invasion, and lymph node/distant metastasis.\",\n      \"method\": \"RNA sequencing, metabolomics (UHPLC-MS/MS), APIP knockdown with migration/invasion assays, in vivo metastasis model, methionine rescue experiment, YAP-APIP transcriptional activation assay\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (transcriptomics, metabolomics, genetic KD, rescue) in a single lab study\",\n      \"pmids\": [\"38423248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"APIP binds to TRAF6, activating downstream NF-κB and JNK signaling to facilitate priming of both canonical NLRP3 and non-canonical caspase-11/caspase-4 inflammasomes; myeloid-specific APIP knockout reduces pyroptosis and systemic inflammation, while APIP overexpression exacerbates it.\",\n      \"method\": \"Co-immunoprecipitation (APIP-TRAF6), myeloid-specific conditional knockout mice (Apip cKO), APIP transgenic mice, APIP knockdown in human macrophages, LPS/bacterial infection models, NF-κB/JNK activity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus multiple genetic models (cKO, transgenic, KD) with defined mechanistic pathway and in vivo phenotype\",\n      \"pmids\": [\"41339302\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"APIP is a multifunctional protein that (1) inhibits apoptosis by binding the Apaf-1 CARD to block apoptosome assembly and by activating AKT/ERK1/2-mediated caspase-9 phosphorylation during hypoxia; (2) acts as the MtnB dehydratase enzyme (zinc-dependent, Glu139* catalytic base, tetrameric) in the methionine salvage pathway, with this enzymatic activity required for suppression of pyroptosis but not apoptosis; (3) binds ERBB3 to stabilize ERBB2-ERBB3 heterodimers and sustain pro-survival signaling; (4) interacts with ADORA2B to prevent lysosomal degradation and activate PKA-CREB/AKT-HIF1α cardioprotective signaling; and (5) binds TRAF6 to prime canonical NLRP3 and non-canonical caspase-11/4 inflammasomes via NF-κB and JNK activation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"APIP is a multifunctional protein that couples metabolic enzyme activity in the methionine salvage pathway with regulation of apoptosis, pyroptosis, and pro-survival signaling. It functions as a zinc-dependent 5-methylthioribulose-1-phosphate dehydratase (MtnB) organized as a tetramer with C4 symmetry, using Glu139 as the catalytic acid/base; this enzymatic activity is required for suppression of caspase-1-mediated pyroptosis but dispensable for its anti-apoptotic functions [PMID:24367089, PMID:23285211]. APIP inhibits mitochondrial apoptosis by binding the Apaf-1 CARD domain in competition with caspase-9 and, independently, by activating AKT and ERK1/2 to phosphorylate caspase-9 during hypoxia; it also binds ERBB3 to stabilize ERBB2–ERBB3 heterodimers sustaining proliferative signaling, and interacts with ADORA2B to prevent its lysosomal degradation and activate PKA-CREB/AKT-HIF1α cardioprotective pathways [PMID:15262985, PMID:17086211, PMID:26942872, PMID:31263105]. APIP additionally binds TRAF6 to activate NF-κB and JNK, thereby priming both canonical NLRP3 and non-canonical caspase-11/4 inflammasomes, with myeloid-specific knockout reducing pyroptosis and systemic inflammation in vivo [PMID:41339302].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing the anti-apoptotic identity of APIP: it was unknown how APIP influenced cell death, and binding to the Apaf-1 CARD in competition with caspase-9 revealed a direct mechanism for blocking apoptosome assembly and downstream caspase activation.\",\n      \"evidence\": \"Co-immunoprecipitation mapping to Apaf-1 CARD, in vitro caspase activation assays, overexpression/knockdown with apoptosis readouts in mammalian cells\",\n      \"pmids\": [\"15262985\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether endogenous APIP levels are sufficient to compete with caspase-9 under physiological conditions\",\n        \"Structural basis of the APIP–Apaf-1 CARD interaction not resolved\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolving a second, Apaf-1-independent anti-apoptotic mechanism: APIP sustains AKT and ERK1/2 activation during hypoxia, leading to inhibitory phosphorylation of caspase-9 at T125 and S196, demonstrating a kinase-mediated survival circuit distinct from apoptosome blockade.\",\n      \"evidence\": \"Stable overexpression in C2C12 cells, PI3K/MEK inhibitor treatment, phospho-mimic/phospho-defective caspase-9 mutants\",\n      \"pmids\": [\"17086211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How APIP activates AKT/ERK1/2 upstream — direct binding partner or indirect effect unknown\",\n        \"Relative contribution of Apaf-1-dependent vs. kinase-dependent mechanisms in vivo\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying APIP as the human MtnB enzyme in the methionine salvage pathway established a metabolic function orthogonal to its anti-apoptotic role, with zinc coordination and the N-terminal region both required for catalysis.\",\n      \"evidence\": \"shRNA knockdown in HeLa with MTA-based growth rescue, Shigella methionine-auxotroph complementation, zinc-binding and phosphorylation-site mutagenesis\",\n      \"pmids\": [\"23285211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether enzymatic and anti-apoptotic functions are regulated independently in cells\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Crystal structure and separation-of-function analysis showed that the MtnB dehydratase activity (Glu139 catalytic base, tetrameric zinc-dependent class II aldolase fold) is specifically required for suppressing caspase-1-mediated pyroptosis but not for suppressing apoptosis, decoupling the metabolic and anti-apoptotic functions mechanistically.\",\n      \"evidence\": \"2.0-Å crystal structure, enzymatic kinetics, E139 active-site mutant tested in pyroptosis and apoptosis assays\",\n      \"pmids\": [\"24367089\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Metabolite(s) linking MtnB activity to caspase-1 suppression not identified\",\n        \"Whether polyamine or other methionine salvage intermediates are the effector species\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Binding of APIP to ERBB3 upon heregulin-β1 stimulation stabilizes ERBB2–ERBB3 heterodimers and prolongs ERK/AKT signaling, providing a receptor-level mechanism for APIP-driven proliferation and tumorigenesis independent of methionine salvage.\",\n      \"evidence\": \"Reciprocal Co-IP of APIP–ERBB3 and ERBB3–ERBB2, APIP knockout/transgenic MEFs, tumor formation assays\",\n      \"pmids\": [\"26942872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Binding interface between APIP and ERBB3 not mapped\",\n        \"Whether APIP affects other ERBB-family heterodimers\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"APIP interaction with ADORA2B prevents lysosomal degradation of both proteins and activates PKA-CREB and AKT-HIF1α signaling, establishing a cardioprotective axis; the ADORA2B D296G variant abolishes binding and protection, linking a human polymorphism to loss of this function.\",\n      \"evidence\": \"Co-IP and proximity ligation assay, APIP transgenic and heterozygous KO mice with myocardial infarction model, ADORA2B D296G knock-in mice\",\n      \"pmids\": [\"31263105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether APIP stabilization of ADORA2B occurs at the plasma membrane or during trafficking\",\n        \"No clinical cohort data linking the D296G variant to cardiac outcomes\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"YAP-driven transcriptional activation of APIP feeds methionine cycle activity, leading to GSK3β phosphorylation/inactivation and epithelial–mesenchymal transition, connecting APIP's metabolic function to metastatic behavior in HNSCC.\",\n      \"evidence\": \"RNA-seq, UHPLC-MS/MS metabolomics, APIP knockdown with invasion assays, in vivo metastasis model, methionine rescue\",\n      \"pmids\": [\"38423248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific methionine cycle metabolite responsible for GSK3β inactivation not identified\",\n        \"Generalizability beyond HNSCC not tested\",\n        \"Single-lab study awaiting independent replication\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"APIP binds TRAF6 to activate NF-κB and JNK, thereby priming canonical NLRP3 and non-canonical caspase-11/4 inflammasomes — revealing a pro-inflammatory role that contrasts with its previously known anti-pyroptotic function.\",\n      \"evidence\": \"Reciprocal Co-IP of APIP–TRAF6, myeloid-specific conditional KO and transgenic mice, LPS/bacterial infection models, human macrophage knockdown\",\n      \"pmids\": [\"41339302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the TRAF6-mediated priming role depends on MtnB enzymatic activity\",\n        \"How the pro-inflammasome priming function is reconciled with earlier caspase-1 pyroptosis suppression attributed to MtnB activity\",\n        \"Binding interface and stoichiometry of APIP–TRAF6 complex unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified model reconciling APIP's apparently opposing roles in promoting inflammasome priming (via TRAF6/NF-κB) yet suppressing pyroptosis (via MtnB activity) is not established; the metabolite intermediates connecting MtnB catalysis to caspase-1 inhibition remain unidentified, and the structural basis of APIP interactions with Apaf-1, ERBB3, ADORA2B, and TRAF6 has not been resolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No co-crystal structure of APIP with any of its protein partners\",\n        \"Metabolite effector(s) linking methionine salvage to pyroptosis suppression unidentified\",\n        \"Context-dependent regulation that switches APIP between pro- and anti-inflammatory modes unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"APAF1\",\n      \"ERBB3\",\n      \"ERBB2\",\n      \"ADORA2B\",\n      \"TRAF6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}